Factors predicting Outcome of total thyroidectomy in young patients with Multiple endocrine neoplasia type 2: A nationwide long-term follow-up study

World Journal of Surgery

Volumn 34, Issue 4, 2010, Pages 852-860

  Schreinemakers, Jennifer M J ^a   Vriens, Menno R ^a   Valk, Gerlof D ^a   De Groot, Jan Willem B ^c   Plukker, John T ^c   Bax, M A ^d   Hamming, Jaap F ^e   Van Der Luijt, Rob B ^a   Aronson, Daniel C ^b,f   Borel Rinkes, Inne H M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b EMMA CHILDREN S HOSPITAL   (Netherlands)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^f RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ANALYSIS OF VARIANCE; ARTICLE; CANCER STAGING; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; CHILD; CODON; FEMALE; FOLLOW UP; GENETICS; HUMAN; LONGITUDINAL STUDY; MALE; MUTATION; NETHERLANDS; NONPARAMETRIC TEST; PATHOLOGY; PREDICTION AND FORECASTING; PRESCHOOL CHILD; RISK FACTOR; SIPPLE SYNDROME; THYROIDECTOMY; TREATMENT OUTCOME;

ADOLESCENT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; CODON; FEMALE; FOLLOW-UP STUDIES; HUMANS; LONGITUDINAL STUDIES; MALE; MULTIPLE ENDOCRINE NEOPLASIA TYPE 2A; MUTATION; NEOPLASM STAGING; NETHERLANDS; PREDICTIVE VALUE OF TESTS; RISK FACTORS; STATISTICS, NONPARAMETRIC; THYROIDECTOMY; TREATMENT OUTCOME;

EID: 77952421576     PISSN: 03642313     EISSN: 14322323     Source Type: Journal    
DOI: 10.1007/s00268-009-0370-2     Document Type: Article

References (24)

1. Kraimps JL, Duh QY, Demeure M et al (1992) Hyperparathy roidism in multiple endocrine neoplasia syndrome. Surgery 112(6):1080-1086 (discussion 1086-1088).
2. Raue F, Frank-Raue K, Grauer A (1994) Multiple endocrine neoplasia type 2 Clinical features and screening. Endocrinol Metab Clin North Am 23(1):137-156.
3. Machens A, Holzhausen HJ, Thanh PN et al (2003) Malignant progression from C-cell hyperplasia to medullary thyroid carcinoma in 167 carriers of RET germline mutations. Surgery 134(3):425-131.
4. Machens A, Ukkat J, Brauckhoff M et al (2005) Advances in the management of hereditary medullary thyroid cancer. J Intern Med 257(1):50-59.
5. Wolfe HJ, Melvin KE, Cervi-Skinner SJ et al (1973) C-cell hyperplasia preceding medullary thyroid carcinoma. N Engl J Med 289(9):437-141.
6. Donis-Keller H, Dou S, Chi D et al (1993) Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 2(7):851-856.
7. Lips CJ, Landsvater RM, Hoppener JW et al (1994) Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 331(13): 828-835.
8. Mulligan LM, Kwok JB, Healey CS et al (1993) Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A. Nature 363(6428):458-460.
9. Machens A, Niccoli-Sire P, Hoegel J et al (2003) Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med 349(16):1517-1525.
10. Skinner MA, Moley JA, Dilley WG et al (2005) Prophylactic thyroidectomy in multiple endocrine neoplasia type 2A. N Engl J Med 353(11):1105-1113.
11. Brandi ML, Gagel RF, Angeli A et al (2001) Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86(12):5658-5671.
12. de Groot JW, Links TP, Rouwe CW et al (2006) Prophylactic thyroidectomy in children who are carriers of a multiple endocrine neoplasia type 2 mutation: description of 20 cases and recommendations based on the literature. Ned Tijdschr Geneeskd 150(6):311-318.
13. Gagel RF, Tashjian AH Jr, Cummings T et al (1988) The clinical outcome of prospective screening for multiple endocrine neoplasia type 2a. An 18-year experience. N Engl J Med 318(8): 478-484.
14. Orlandi F, Caraci P, Mussa A et al (2001) Treatment of medullary thyroid carcinoma: an update. Endocr Relat Cancer 8(2):135-147.
15. Machens A, Dralle H (2007) Genotype-phenotype based surgical concept of hereditary medullary thyroid carcinoma. World J Surg 31(5):957-968.
16. Dralle H, Gimm O, Simon D et al (1998) Prophylactic thyroidectomy in 75 children and adolescents with hereditary medullary thyroid carcinoma: German and Austrian experience. World J Surg 22(7):744-750 (discussion 750-741).
17. Gill JR, Reyes-Mugica M, Iyengar S et al (1996) Early presentation of metastatic medullary carcinoma in multiple endocrine neoplasia, type IIA: implications for therapy. J Pediatr 129(3): 459-464.
18. Samaan NA, Draznin MB, Halpin RE et al (1991) Multiple endocrine syndrome type IIb in early childhood. Cancer 68(8): 1832-1834.
19. Skinner MA, DeBenedetti MK, Moley JF et al (1996) Medullary thyroid carcinoma in children with multiple endocrine neoplasia types 2A and 2B. J Pediatr Surg 31(1):177-181 (discussion 181-172).
20. Stjernholm MR, Freudenbourg JC, Mooney HS et al (1980) Medullary carcinoma of the thyroid before age 2 years. J Clin Endocrinol Metab 51(2):252-253.
21. Siggelkow H, Melzer A, Nolte W et al (2001) Presentation of a kindred with familial medullary thyroid carcinoma and Cys611Phe mutation of the RET proto-oncogene demonstrating low grade malignancy. Eur J Endocrinol 144(5):467-473.
22. Lindskog S, Nilsson O, Jansson S et al (2004) Phenotypic expression of a family with multiple endocrine neoplasia type 2A due to a RET mutation at codon 618. Br J Surg 91(6):713-718.
23. Neocleous V, Passalaris T, Spanou E et al (2004) Description of the first two seemingly unrelated Greek Cypriot families with a common C618R RET proto-oncogene mutation. Genet Test 8(2):163-168.
24. Frohnauer MK, Decker RA (2000) Update on the MEN 2A c804 RET mutation: is prophylactic thyroidectomy indicated? Surgery 128(6):1052-1057 (discussion 1057-1058).